Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?

To: zax who wrote (1105)	4/14/2020 4:23:59 PM
From: emertius	Respond to of 22884

There is a small (6 subjects?) study claiming great success in COVID-19 published in a Chinese journal and an Italian study describing the ability of the drug to block the pulmonary pathology characteristic of COVID-19 infections. For some unknown reason the article in the Italian journal has been taken down. Go to the OMEROS IV and stocktwits boards to get the details. The company itself has been very silent on this issue but has announced that the entire inventory of the drug set aside for compassionate use is no longer available.